Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 6
2004 5
2005 8
2006 3
2007 4
2008 9
2009 9
2010 11
2011 16
2012 11
2013 9
2014 9
2015 7
2016 8
2017 6
2018 8
2019 14
2020 1
2021 5
2022 3
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
The impact of coding germline variants on contralateral breast cancer risk and survival.
Morra A, Mavaddat N, Muranen TA, Ahearn TU, Allen J, Andrulis IL, Auvinen P, Becher H, Behrens S, Blomqvist C, Bojesen SE, Bolla MK, Brauch H, Camp NJ, Carvalho S, Castelao JE, Cessna MH, Chang-Claude J, Chenevix-Trench G; NBCS Collaborators; Czene K, Decker B, Dennis J, Dörk T, Dorling L, Dunning AM, Ekici AB, Eriksson M, Evans DG, Fasching PA, Figueroa JD, Flyger H, Gago-Dominguez M, García-Closas M, Geurts-Giele WRR, Giles GG, Guénel P, Gündert M, Hahnen E, Hall P, Hamann U, Harrington PA, He W, Heikkilä P, Hooning MJ, Hoppe R, Howell A, Humphreys K; kConFab Investigators; Jakubowska A, Jung AY, Keeman R, Kristensen VN, Lubiński J, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Mavroudis D, Milne RL, Mulligan AM, Newman WG, Park-Simon TW, Peterlongo P, Pharoah PDP, Rhenius V, Saloustros E, Sawyer EJ, Schmutzler RK, Shah M, Spurdle AB, Tomlinson I, Truong T, van Veen EM, Vreeswijk MPG, Wang Q, Wendt C, Yang XR, Nevanlinna H, Devilee P, Easton DF, Schmidt MK. Morra A, et al. Among authors: heikkila p. Am J Hum Genet. 2023 Mar 2;110(3):475-486. doi: 10.1016/j.ajhg.2023.02.003. Epub 2023 Feb 23. Am J Hum Genet. 2023. PMID: 36827971 Free PMC article.
Malignancy in pheochromocytomas.
Salmenkivi K, Heikkilä P, Haglund C, Arola J. Salmenkivi K, et al. Among authors: heikkila p. APMIS. 2004 Sep;112(9):551-9. doi: 10.1111/j.1600-0463.2004.apm1120901.x. APMIS. 2004. PMID: 15601303 Review.
NTHL1 is a recessive cancer susceptibility gene.
Nurmi AK, Pelttari LM, Kiiski JI, Khan S, Nurmikolu M, Suvanto M, Aho N, Tasmuth T, Kalso E, Schleutker J, Kallioniemi A, Heikkilä P; FinnGen; Aittomäki K, Blomqvist C, Nevanlinna H. Nurmi AK, et al. Among authors: heikkila p. Sci Rep. 2023 Nov 30;13(1):21127. doi: 10.1038/s41598-023-47441-w. Sci Rep. 2023. PMID: 38036545 Free PMC article.
Reply-Letter to the editor.
Takala SJ, Heikkilä P, Nevanlinna H, Blomqvist C, Mattson J. Takala SJ, et al. Among authors: heikkila p. Breast J. 2019 Nov;25(6):1332. doi: 10.1111/tbj.13478. Epub 2019 Jul 28. Breast J. 2019. PMID: 31353773 No abstract available.
Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia.
Nyholm I, Hukkinen M, Pihlajoki M, Davidson JR, Tyraskis A, Lohi J, Heikkilä P, Hänninen S, Andersson N, Eloranta K, Carpén O, Heikinheimo M, Davenport M, Pakarinen MP. Nyholm I, et al. Among authors: heikkila p. Hepatology. 2023 Apr 1;77(4):1263-1273. doi: 10.1097/HEP.0000000000000048. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36692476 Free PMC article.
[Dormancy of tumor cells].
Strien L, Joensuu K, Heikkilä P. Strien L, et al. Among authors: heikkila p. Duodecim. 2013;129(21):2245-52. Duodecim. 2013. PMID: 24340675 Review. Finnish.
Clever-1 positive macrophages in breast cancer.
Mutka M, Virtakoivu R, Joensuu K, Hollmén M, Heikkilä P. Mutka M, et al. Among authors: heikkila p. Breast Cancer Res Treat. 2022 Oct;195(3):237-248. doi: 10.1007/s10549-022-06683-4. Epub 2022 Aug 2. Breast Cancer Res Treat. 2022. PMID: 35917053 Free PMC article.
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
O'Loughlin M, Andreu X, Bianchi S, Chemielik E, Cordoba A, Cserni G, Figueiredo P, Floris G, Foschini MP, Heikkilä P, Kulka J, Liepniece-Karele I, Regitnig P, Reiner A, Ryska A, Sapino A, Shalaby A, Stovgaard ES, Quinn C, Walsh EM, Zolota V, Glynn SA, Callagy G. O'Loughlin M, et al. Among authors: heikkila p. Breast Cancer Res Treat. 2018 Aug;171(1):1-9. doi: 10.1007/s10549-018-4825-8. Epub 2018 May 17. Breast Cancer Res Treat. 2018. PMID: 29774470
140 results